Scalper1 News
A new analyst report from Cowen & Co. offers an upbeat assessment of medical research and equipment stocks ahead of first-quarter earnings, thanks to improving end markets. In his report on the Life Sciences and Diagnostic Tools sectors on Tuesday, analyst Doug Schenkel wrote that “most companies are poised to meet or beat Q1 expectations.” That expectation — combined with “confidence-building, forward-looking commentary” and positive updates on Scalper1 News
Scalper1 News